Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adamis Pharmaceuticals
Adamis Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Symjepi
Epinephrine
2017-06-15
2024-2039
Septic shock
,
Hypotension
,
Ventricular tachycardia
,
Anaphylaxis
,
Bradycardia
,
Heart arrest
,
Open-angle glaucoma
,
Heart block
,
Airway obstruction
,
Bronchial spasm
,
Ventricular fibrillation
,
Pain
,
Postoperative pain
,
Cardiac arrhythmias
,
Burns
,
Esophageal diseases
,
Ventricular premature complexes
,
Mouth diseases
,
Paroxysmal tachycardia
,
Substance withdrawal syndrome
Zimhi
Naloxone
2021-10-15
2024-2041
Septic shock
,
Pain
,
Opioid-related disorders
,
Heroin dependence
,
Respiration disorders
,
Postoperative pain
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use